Evan J Peterson
Overview
Explore the profile of Evan J Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Addison J, Peterson E, Meyenburg L
Ann Pharmacother
. 2023 Feb;
57(11):1241-1247.
PMID: 36803069
Background: Acetazolamide has been used for diuretic-induced metabolic alkalosis, but the preferred dose, route, and frequency of administration remain unknown. Objective: The purpose of this study was to characterize dosing...
2.
Vogel S, Smith L, Peterson E
J Pharm Pract
. 2018 Dec;
33(3):356-363.
PMID: 30541367
Objective: To review evidence behind anticoagulants in cancer-associated venous thromboembolism (VTE) with a focus on low-molecular-weight heparins (LMWH) and the role of direct oral anticoagulants (DOACs). Data Sources: PubMed was...
3.
Peterson E, Ng T, Patel K, Lou M, Elkayam U
J Int Med Res
. 2018 Jun;
46(9):3665-3674.
PMID: 29865919
Objectives Hypoalbuminemia occurs in 25% to 76% of patients hospitalized for acute heart failure (HF) and is associated with increased mortality. Hypoalbuminemia may predispose patients to intravascular volume depletion, hypotension,...
4.
Helmink B, Ragsdale C, Peterson E, Merkel K
J Pediatr Pharmacol Ther
. 2016 May;
21(2):146-54.
PMID: 27199622
Objectives: Evidence suggests palivizumab may be beneficial for respiratory syncytial virus (RSV) infection in pediatric patients, although it is only approved by the US Food and Drug Administration for RSV...
5.
Roberts K, Knight T, Padilla-Tolentino E, Murthy M, Peterson E
Thrombosis
. 2016 Feb;
2015:414523.
PMID: 26881071
Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not...
6.
Daley M, Trust M, Peterson E, Luftman K, Miller A, Ali S, et al.
Am Surg
. 2016 Feb;
82(2):175-80.
PMID: 26874143
Thromboelastography (TEG) with platelet mapping has been proposed as an assay to detect the presence of antiplatelet agents (APA), yet no study has evaluated TEG markers of platelet dysfunction in...
7.
Daley M, Murthy M, Peterson E
Ther Adv Drug Saf
. 2015 Apr;
6(2):57-66.
PMID: 25922654
Acute pulmonary embolism represents a major complication of venous thromboembolism that is associated with high morbidity and mortality. Guidelines recommend the rapid initiation of anticoagulation and consideration of thrombolytic therapy...
8.
Faust A, Peterson E
J Emerg Med
. 2014 Feb;
46(4):525-9.
PMID: 24508114
Background: Dabigatran is an oral, reversibly bound, direct thrombin inhibitor currently approved in the United States for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In...
9.
Peterson E, Reaves A, Smith J, Oliphant C
Hosp Pharm
. 2014 Jan;
48(2):127-33.
PMID: 24421450
Background: Guidelines recommend that all patients with atrial fibrillation and a history of ischemic stroke should receive an anticoagulant. Prior analyses show that warfarin is underutilized in most populations. Objective:...
10.
Chan C, Peterson E, Ng T
Ann Pharmacother
. 2012 Nov;
46(11):1554-8.
PMID: 23136355
Objective: To determine whether thiazides have a chronic antihypertensive effect, in the absence of diuresis, in patients with severe renal disease (creatinine clearance <30 mL/min) or in those receiving dialysis....